Carlyle, SK Capital, Beacon Set To Close Bluebird Bio Acquisition
Written by Emily J. Thompson, Senior Investment Analyst
Source: NASDAQ.COM
Acquisition Announcement: Carlyle Group, SK Capital Partners, and Beacon Parent Holdings confirmed that their acquisition of bluebird bio will finalize on June 2 after meeting all tender offer conditions.
Tender Offer Details: The tender offer, which ran from March 7 to May 29, resulted in approximately 59.8% of bluebird's outstanding shares being validly tendered, with the acquisition structured as a merger without a stockholder vote.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
